United States FDA: The clinical benefits of NovoCure cancer treatment devices are still unclear
2026-11-09 20:13:31
According to CoinMeta, the U.S. Food and Drug Administration (FDA) stated in its review that the clinical benefits of the cancer treatment devices under NovoCure are not yet clear. As a result, the company's stock price fell by 5% before the market opened.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.